These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27143866)

  • 1. Multiple myeloma in the very elderly patient: challenges and solutions.
    Willan J; Eyre TA; Sharpley F; Watson C; King AJ; Ramasamy K
    Clin Interv Aging; 2016; 11():423-35. PubMed ID: 27143866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elderly patients with multiple myeloma: towards a frailty approach?
    Zweegman S; Engelhardt M; Larocca A;
    Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of multiple myeloma in elderly patients: consensus of the Geriatric Oncology Working Group of the German Society of Hematologic Oncology and the German Society of Geriatrics].
    Genvresse I; Wedding U; Bokemeyer C; Späth-Schwalbe E
    Onkologie; 2001 Aug; 24(4):386-90. PubMed ID: 11574768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise review - Treatment of multiple myeloma in the very elderly: How do novel agents fit in?
    Kint N; Delforge M
    J Geriatr Oncol; 2016 Sep; 7(5):383-9. PubMed ID: 27567255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and Strategies in the Management of Multiple Myeloma in the Elderly Population.
    Zanwar S; Abeykoon JP; Kapoor P
    Curr Hematol Malig Rep; 2019 Apr; 14(2):70-82. PubMed ID: 30820879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
    Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
    PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Considerations for Transplant-Ineligible Multiple Myeloma.
    Elnair R; Holstein S
    Oncology (Williston Park); 2021 Apr; 35(4):170-182. PubMed ID: 33886251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Newly Diagnosed Elderly Multiple Myeloma Patients.
    Antoine-Pepeljugoski C; Braunstein MJ
    Curr Oncol Rep; 2019 May; 21(7):64. PubMed ID: 31127403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for elderly patients with multiple myeloma.
    Focosi D
    Lancet; 2008 Mar; 371(9617):983-4; author reply 984-5. PubMed ID: 18358918
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review.
    Sanchez L; Barley K; Richter J; Franz J; Cho HJ; Jagannath S; Madduri D; Parekh S; Richard S; Chari A
    Expert Rev Hematol; 2020 Sep; 13(9):943-958. PubMed ID: 32731770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma: how far have we come?
    Anderson KC
    Mayo Clin Proc; 2003 Jan; 78(1):15-7. PubMed ID: 12528872
    [No Abstract]   [Full Text] [Related]  

  • 12. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.
    Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV
    Blood; 2015 Mar; 125(13):2068-74. PubMed ID: 25628469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple myeloma in young adults].
    Fernández Ramos O; Trujillo Fernández R; Wilford de León M; Roche Bermúdez MA
    Rev Esp Oncol; 1985; 32(1):109-16. PubMed ID: 3842999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implications.
    Kunacheewa C; Manasanch EE
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101152. PubMed ID: 32139017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma: Current advances and future directions.
    Ola Landgren C
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101155. PubMed ID: 32139007
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.
    Auner HW; Garderet L; Kröger N
    Br J Haematol; 2015 Nov; 171(4):453-62. PubMed ID: 26213240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to treat elderly patients with multiple myeloma: combination of therapy or sequencing.
    Palumbo A; Gay F
    Hematology Am Soc Hematol Educ Program; 2009; ():566-77. PubMed ID: 20008241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients.
    Gavriatopoulou M; Fotiou D; Koloventzou U; Roussou M; Migkou M; Ntanasis-Stathopoulos I; Kanellias N; Ziogas DC; Panagiotidis I; Gika D; Eleutherakis-Papaiakovou E; Terpos E; Kastritis E; Dimopoulos MA
    Leuk Lymphoma; 2019 Mar; 60(3):619-628. PubMed ID: 30628505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma.
    Ise M; Matsubayashi K; Tsujimura H; Kumagai K
    Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):e59-64. PubMed ID: 26997107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.